Point of Care Testing for Infectious Diseases Market: Latest Trends, Demand & Analysis 2020-2025

1
Point of Care Testing for Infectious Diseases
Market

• Size 2019, By Infection Type (HIV, Clostridium
  difficile, HBV, Pneumonia or Streptococcus
  associated infections, RSV, HPV, Influenza/Flu,
  HCV, MRSA, TB, HSV and Others), By Usage Area
  (Hospitals, Clinica, Clinical Laboratories,
  Assisted Living Facilities, Others), By Region
  and Forecast 2019 to 2025

Single Use License US 4400
Request Sample
2
Point of Care Testing for Infectious Diseases
Market Size and Share-Global Forecast to 2025

• The global point of care diagnostics for
  infectious diseases market is anticipated to
  reach a value of USD 2.2 billion by 2025, growing
  at a CAGR of 9.1 during the forecast period from
  2019 to 2025. Recent pandemic crisis and the
  consistent growth in incidence of infections,
  along with the growing trend of consumer centric
  services to patients contribute to the growth of
  this market. Furthermore, appropriate deployment
  of point of care testing at healthcare and
  inpatient settings also allow in cost containment
  in the long run to hospital as it efficiently
  assists in reducing lead time for diagnosis,
  patient stay and ultimately healthcare cost.
• Additionally, growing prevalence in pediatric and
  geriatric populations along with increasing pool
  of this population sets are also attributes to
  the increased demand for point of care diagnostic
  tools for infections. Further innovation and
  technological advancements will open up new
  opportunistic avenues for market development.
• Browse Complete Research Report _at_
  https//www.adroitmarketresearch.com/industry-repo
  rts/point-of-care-testing-for-infectious-diseases-
  market

3
Point of Care Testing for Infectious Diseases
Market Size and Share-Global Forecast to 2025

• Adroit Market Research report on global point of
  care testing for infectious diseases market gives
  a holistic view of the market from 2015 to 2025,
  which includes factors such as market drivers,
  restraints, opportunities and challenges. The
  market has been studied for historic years from
  2015 to 2017, with the base year of estimation as
  2018 and forecast from 2019 to 2025. The report
  covers the current status and future traits of
  the market at global as well as country level. In
  addition, the study also assesses the market
  based on Porter's five forces analysis and
  positions the key players based on their product
  portfolio, geographic footprint, strategic
  initiatives and overall revenue. Prominent
  players operating in the global point of care
  testing for infectious diseases market have been
  studied in detail.
• Point of care testing refers to diagnostic
  procedures performed at patient site for
  providing swift test results. Diagnosis of
  infections such as tuberculosis, influenza, STDs,
  and HIV along with some tropical diseases has
  become a convenient affair through POC testing
  and thus has also resulted in disease containment
  and public health management to a considerable
  extent. These tests enable prompt access to care
  while reducing the risk of disease transmission.
  Furthermore, POC testing also assists in
  efficient disease management in remote areas. The
  latest developments in the nature of diagnostic
  technologies and delivery of healthcare services
  have led to significant growth in demand for
  point of care tests for infection diagnosis in
  public healthcare services.

4
Point of Care Testing for Infectious Diseases
Market Size and Share-Global Forecast to 2025

• Geographically, North America dominates the
  global point of care infectious disease
  diagnostics market. High awareness, better
  availability of POC kits, and high incidence of
  infections in the region. Asia Pacific, despite
  its large population base and high incidence of
  infectious diseases, especially those like
  tropical diseases, has not yet reached the market
  status as North America. However, the growth of
  Asia Pacific market has been picking pace and is
  anticipated to witness a continued trend through
  the forecast period. China and Indian markets
  will spearhead the growth in Asia Pacific,
  through attributes such as growing awareness,
  rapid development of healthcare infrastructure,
  improving purchasing power and growing funding of
  domestic governments.
• Introduction of novel point of care testing
  technologies such as lab on chip and
  microfluidics will open new market development
  opportunities in the future. Additionally,
  changes in regulatory environment in terms of
  speeding up the process of approval will further
  render to the market growth. Major companies
  operating in the point of care testing for
  infectious diseases market are Thermo Fisher
  Scientific Inc., Alere Inc., Chembio Diagnostic
  Systems Inc., Trinity Biotech plc, Quest
  Diagnostics Inc., F. Hoffmann-La Roche Ltd.,
  bioMérieux SA, Bio-Rad Labs Inc., Cardinal
  Health, BD Company, Ortho-Clinical
  Diagnostics and others.
• Purchase This Report _at_ https//www.adroitmarketres
  earch.com/researchreport/purchase/1580

5
Point of Care Testing for Infectious Diseases
Market Size and Share-Global Forecast to 2025

• Key Segments of the Global Point of Care Testing
  for Infectious Diseases Market
• Infection Overview, 2015-2025 (USD Million)
• HIV
• Clostridium difficile
• HBV
• Pneumonia or Streptococcus associated infections
• Respiratory syncytial virus (RSV)
• HPV
• Influenza/Flu
• HCV
• MRSA
• TB and drug-resistant TB
• HSV (Herpes Simplex Virus)
• Others

6
Point of Care Testing for Infectious Diseases
Market Size and Share-Global Forecast to 2025

• Usage Area Overview, 2015-2025 (USD Million)
• Hospitals
• Clinics
• Home Care
• Clinical Laboratories
• Assisted Living Facilities
• Others

7
Point of Care Testing for Infectious Diseases
Size and Share-Global Forecast to 2025

• Regional Overview, 2015-2025 (USD Million)
• North America
• U.S.
• Canada
• Europe
• Germany
• United Kingdom
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East Africa

8
About Us

• Adroit Market Research is an India-based business
  analytics and consulting company. Our target
  audience is a wide range of corporations,
  manufacturing companies, product/technology
  development institutions and industry
  associations that require understanding of a
  markets size, key trends, participants and
  future outlook of an industry. We intend to
  become our clients knowledge partner and provide
  them with valuable market insights to help create
  opportunities that increase their revenues. We
  follow a code Explore, Learn and Transform. At
  our core, we are curious people who love to
  identify and understand industry patterns, create
  an insightful study around our findings and churn
  out money-making roadmaps. Our analysts have
  tracked high growth markets in chemicals
  materials, healthcare pharmaceuticals,
  semiconductor electronics, energy power, food
  retail, consumer goods, technology, and
  machinery equipment sectors across the world to
  identify new opportunities, potential customers,
  prepare go-to-market (GTM) strategies, identify
  segments for revenue growth for companies, and
  many more.

• US Headquarters3131 McKinney Ave Ste 600
  Dallas, TX 75204 ,U.S.A 

• Phone [phone]
• Email sales_at_adroitmarketresearch.com